Hesai Group Sponsored ADR (HSAI) closed the last trading session at $23.26, gaining 9.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $30.15 indicates a 29.6% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $4.76. While the lowest estimate of $23.30 indicates a 0.2% increase from the current price level, the most optimisti ...

Shares of Great Lakes Dredge & Dock (GLDD) have gained 3.2% over the past four weeks to close the last trading session at $11.92, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15 indicates a potential upside of 25.8%.The mean estimate comprises four short-term price targets with a standard deviation of $1.41. While the lowest estimate of $14.00 indicates a 17.5% increase from ...

Pharming Group N.V. Sponsored ADR (PHAR) closed the last trading session at $12.66, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $30.67 indicates a 142.3% upside potential.The average comprises three short-term price targets ranging from a low of $14.00 to a high of $41.00, with a standard deviation of $14.57. While the lowest estimate indicates an increase of 10.6 ...

Core Viewpoint - Natural Gas Services (NGS) shares have increased by 6.8% recently, with analysts suggesting a potential upside of 41.7% based on a mean price target of $36.25 [1][11]. Price Targets - The average price target for NGS ranges from a low of $32.00 to a high of $45.00, with a standard deviation of $5.97, indicating variability among analysts [2]. - The lowest estimate suggests a 25.1% increase, while the highest points to a 75.9% upside [2]. Analyst Sentiment - There is strong agreement among analysts regarding NGS's ability to report better earnings, which supports the expectation of an upside [4][11]. - Over the past 30 days, the Zacks Consensus Estimate for the current year has risen by 5.7%, with no negative revisions [12]. Zacks Rank - NGS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction indicated by these targets appears to be a useful guide for potential price movement [14].

U.S. Physical Therapy (USPH) closed the last trading session at $86.71, gaining 17.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $109.67 indicates a 26.5% upside potential.The average comprises six short-term price targets ranging from a low of $98.00 to a high of $124.00, with a standard deviation of $8.91. While the lowest estimate indicates an increase of 13% from the curre ...

Group 1 - Avadel (AVDL) shares have increased by 32.7% over the past four weeks, closing at $12.75, with a mean price target of $17.5 indicating a potential upside of 37.3% [1] - The mean estimate consists of eight short-term price targets with a standard deviation of $3.38, where the lowest estimate is $12.00 (5.9% decline) and the highest is $22.00 (72.6% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 15.5% over the past month [11][12] Group 2 - AVDL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - The clustering of price targets with a low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] - While price targets can be misleading, the direction they imply may serve as a useful guide for potential price movements [10][14]

Shares of Payoneer Global Inc. (PAYO) have gained 2.5% over the past four weeks to close the last trading session at $6.64, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $9.56 indicates a potential upside of 44%.The mean estimate comprises nine short-term price targets with a standard deviation of $1.67. While the lowest estimate of $7.00 indicates a 5.4% increase from the cur ...

Shares of Superior Group (SGC) have gained 2.7% over the past four weeks to close the last trading session at $11.42, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $17.8 indicates a potential upside of 55.9%.The mean estimate comprises five short-term price targets with a standard deviation of $4.15. While the lowest estimate of $14.00 indicates a 22.6% increase from the curre ...

Great Lakes Dredge & Dock (GLDD) closed the last trading session at $11.28, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $15 indicates a 33% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $1.41. While the lowest estimate of $14.00 indicates a 24.1% increase from the current price level, the most optimistic ana ...

Core Viewpoint - Genmab A/S Sponsored ADR (GMAB) has seen a 3.8% increase in share price over the past four weeks, closing at $22.69, with a potential upside of 33.8% based on Wall Street analysts' mean price target of $30.36 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $20.00 to a high of $46.00, with a standard deviation of $8.82, indicating variability among analysts [2] - The lowest estimate suggests an 11.9% decline from the current price, while the highest estimate indicates a 102.7% upside [2] Analyst Sentiment - Analysts show a consensus that GMAB will report better earnings than previously estimated, which historically correlates with stock price increases [4][11] - The Zacks Consensus Estimate for the current year has increased by 0.1% over the past month, with one estimate rising and no negative revisions [12] Zacks Rank - GMAB holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the extent of GMAB's potential gains, it does provide a useful indication of the expected direction of price movement [14]